The Multi-Modal Defense Against Cancer | Dr Tarek Mouhieddine

Dr. Tarek Mouhieddine breaks down the "Multi-Modal Defense"—a comprehensive screening strategy that combines advanced blood tests (like DNA methylation tracking) with non-invasive MRIs to detect asymptomatic cancers before traditional symptoms appear.. Some links are affiliate links so we will earn a commission when they are used to purchase products. If you would like to support our channel please consider joining our Patreon https://patreon.com/ModernHealthspan ~~~~~~~~~~~~~~ Resources for Cellular & Mitochondrial Support: While early detection testing is our best defensive radar, supporting cellular health on a daily basis is just as critical. Here are the independent protocols we use to support cellular integrity: AX3 Life Astaxanthin (Advanced cellular membrane protection): https://tinyurl.com/2t3w26nw (Use code MODERN20 for 20% off) MitoQ Pure (Targeted mitochondrial antioxidant support): https://tinyurl.com/3hxy9s7x Qualia Senolytic (Supporting the clearance of damaged senescent cells): https://bit.ly/4jlaibe (Use code MODERN for 15% off) ~~~~~~~~~~~~~~ Most cancers are completely asymptomatic during Stage 1, which is exactly why they are frequently missed until advanced stages. In this clip, oncologist Dr. Tarek Mouhieddine from POM Health breaks down how multi-cancer early detection (MCED) protocols are revolutionizing preventative screening. We discuss the Galleri test by Grail, a non-invasive blood test that screens for over 50 cancer subtypes by analyzing circulating cell-free DNA and tracking specific methylation signatures. Dr. Mouhieddine discusses why relying on a single test isn't enough, explaining how POM Health overlays advanced blood assays, tumor markers (like CEA, PSA, and CA 125), and full-body MRIs to drastically lower the risk of false negatives. Discover how a multi-modal, telehealth-guided approach offers a safer, less invasive, and highly comprehensive alternative to traditional screening methods. ⚠️ CLINICAL SCREENING NOTICE & MEDICAL DISCLAIMER This video is for educational and informational purposes only. Multi-cancer early detection (MCED) tests, such as the Galleri test, are emerging diagnostic tools designed to complement, not replace, standard age-appropriate cancer screenings recommended by healthcare authorities (such as colonoscopies or mammograms). Diagnostic tests can yield false positives or false negatives. This content does not constitute medical advice, diagnosis, or screening prescriptions. Always consult with a qualified physician or oncologist regarding your individual cancer risks, screening results, and preventative medical options. 📚 Chapters 00:00 Why We Need Better Cancer Detection Tools 00:56 Introducing Multi-Cancer Early Detection Blood Tests 05:15 How the Galleri Test Works: DNA Methylation Explained 07:27 From Blood Draw to Results: The Pom Health Process 10:20 Why One Test Isn't Enough: Layering Multiple Modalities 12:39 Three Non-Invasive Ways to Catch Colon Cancer 🌐Links in this video POM Health Home Page https://www.pomhealth.xyz/ Dr Mouhieddine's page at Dana-Farber Cancer Institute #CancerScreening #EarlyDetection #GalleriTest #OncologyNews